This content is machine translated Multiple sclerosis Avoiding the nocebo trap with natalizumab biosimilars Monoclonal antibodies such as natalizumab are indispensable for multiple sclerosis therapy. A first recently approved biosimilar is clinically equivalent, as studies have shown. Nevertheless, reservations are widespread in practice. Patients...…
View Post 6 min This content is machine translated COPD and comorbidities Exacerbation frequency is associated with cardiopulmonary disease burden Exacerbation severity and frequency are crucial for the prognosis of COPD, but also appear to have a major impact on the course of comorbidities. There is a growing body of...…
View Post 12 min This content is machine translated Multiple myeloma DREAMM-8: Key study in the development of BCMA therapy up to DREAMM-14 The DREAMM-8 data presented at this year’s ASCO provided robust evidence of the efficacy and tolerability of the BPd combination (belantamab mafodotin, pomalidomide and dexamethasone) for the treatment of recurrent...…
View Post 9 min This content is machine translated Catheter ablation for atrial fibrillation 2025 Pulsed field versus radio frequency – where do we stand? In the treatment of atrial fibrillation (AF), catheter ablation has developed from a specialized option to the mainstay of a modern rhythm strategy within a decade. In 2025, two developments...…
View Post 8 min This content is machine translated Atopic dermatitis From skin barrier disorder to atopic march? An early onset and persistent course of atopic dermatitis are the strongest predictors of atopic march. New diagnostic methods such as electrical impedance spectroscopy and the analysis of biomarkers from...…
View Post 10 min This content is machine translated From the late residual valve to independent therapy Tricuspid interventions 2025 For a long time, the tricuspid valve was considered the “forgotten valve”. In 2025, there is nothing left of it. Within just a few years, an independent, evidence-based field has...…
View Post 3 min This content is machine translated Friedreich's ataxia Treatment options have improved Friedreich’s ataxia is a hereditary neurodegenerative disease that is classically characterized by uncoordinated movements, postural and gait disorders, as well as balance and visual disorders. Subgroups of those affected also...…
View Post 11 min This content is machine translated Late-Breaking Science Antithrombotics & rhythm The ESC Congress 2025 in Madrid presented several studies in hot-line and late-breaking sessions that have a direct impact on the care of patients with atrial fibrillation, coronary heart disease,...…
View Post 3 min This content is machine translated Prostate cancer Diagnosis without drama – ESMO 2025 under the banner of differentiated patient management The annual ESMO Congress of the European Society for Medical Oncology, which was held this year in Berlin from October 17 to 21, 2025, offered an impressive variety of topics...…
View Post 8 min This content is machine translated Pneumococcal conjugate vaccine (PCV) Best possible serotype coverage in the respective age group The disease burden of pneumococcal infections is highest in <5-year-old children and ≥65-year-old adults, as well as in the presence of certain comorbidities and in immunocompromised individuals. In Switzerland, there...…
View Post 9 min This content is machine translated Psoriasis: intervening in the inflammatory cascade Advantages of early biologic therapy and oral peptide as a beacon of hope The question of whether early biologics treatment can have a lasting effect on the course of psoriasis is the focus of numerous research projects. The GUIDE study investigated the corresponding...…
